Julie Leask Selected Research

Julie Leask Research Topics

15	Human Influenza (Influenza) 07/2021 - 02/2009
7	Whooping Cough (Pertussis) 10/2021 - 04/2011
4	Vaccine-Preventable Diseases 01/2022 - 01/2014
4	Infections 01/2021 - 04/2013
4	Measles 01/2015 - 01/2006
4	Mumps 01/2015 - 01/2006
3	COVID-19 02/2022 - 10/2020
3	Rubella (German Measles) 05/2012 - 01/2006
2	Diphtheria 10/2021 - 04/2011
2	Tetanus 10/2021 - 04/2011
2	Autistic Disorder (Autism) 05/2018 - 05/2012
2	Hepatitis B 01/2015 - 04/2011
1	Psychological Trauma 06/2022
1	Wounds and Injuries (Trauma) 06/2022
1	Pneumococcal Infections 06/2020
1	Hypersensitivity (Allergy) 05/2018
1	Communicable Diseases (Infectious Diseases) 12/2017
1	Myopia 01/2017
1	Confusion (Bewilderment) 01/2017
1	Virus Diseases (Viral Diseases) 05/2014
1	Autism Spectrum Disorder 05/2012
1	Chickenpox 04/2011
1	Neonatal hemochromatosis 08/2008
1	Asthma (Bronchial Asthma) 12/2003
1	Neoplasms (Cancer) 12/2003

27	VaccinesIBA 02/2022 - 12/2003
3	Pentetic Acid (DTPA)FDA LinkGeneric 10/2021 - 08/2011
2	COVID-19 VaccinesIBA 06/2022 - 10/2020
2	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2021 - 05/2014
2	Measles-Mumps-Rubella Vaccine (MMR Vaccine)IBA 05/2012 - 01/2006
1	Tyr sulfate(1)- enkephalinamide-Leu (LETS)IBA 01/2022
1	SolutionsIBA 10/2020
1	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 06/2020
1	CI 22IBA 05/2018
1	SuspensionsIBA 01/2017
1	Rubella VaccineIBA 01/2015
1	serogroup C meningococcal conjugate vaccineIBA 01/2015
1	Neuraminidase (Sialidase)IBA 02/2009
1	Zanamivir (Relenza)FDA Link 02/2009
1	Antiviral Agents (Antivirals)IBA 02/2009
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2009
1	Oseltamivir (Tamiflu)FDA Link 02/2009

1	Medical Day Care (Partial Hospitalization) 07/2011